← Back to Search

Behavioural Intervention

Breathe Easier App for Lung Cancer (Breathe Easier Trial)

Q: Are additional participants being solicited for this investigation?

<p>Evidently, clinicaltrials.gov does not indicate this research trial is actively recruiting any more participants; it was originally posted on October 2nd 2023 and last edited on September 22th 2023. Fortunately, there are numerous other trials that seeking enrolment right now with a total of 2086.</p>

Phase < 1

Waitlist Available

Led By Otis Owens, PhD

Research Sponsored by University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Must be a White or African-American survivor of NSCLC, stages I-III

Timeline

Screening 3 weeks

Treatment Varies

Follow Up administered prior to the start of intervention and immediately following the intervention.

Awards & highlights

Breathe Easier Trial Summary

This trial evaluates if an app helps lung cancer survivors manage their symptoms and improve their quality of life.

Who is the study for?

This trial is for White or African-American survivors of non-small cell lung cancer (NSCLC) stages I-III. Participants must have a smartphone, internet access, and be willing to use a mobile app for daily meditations and gentle exercises over 8 weeks.Check my eligibility

What is being tested?

The 'Breathe Easier' progressive web application is being tested to see if it can help lung cancer survivors manage symptoms like shortness of breath and fatigue, and improve their quality of life. The study will compare users of the app with those who do not receive any intervention.See study design

What are the potential side effects?

Since this intervention involves mindfulness practices through an app, there are no direct medical side effects expected from its use. However, participants may experience varying levels of engagement or satisfaction.

Breathe Easier Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a White or African-American survivor of early-stage lung cancer.

Breathe Easier Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ administered only to intervention group immediately following the 8-week intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~administered only to intervention group immediately following the 8-week intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and administered only to intervention group immediately following the 8-week intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Dyspnea (MRC Breathlessness Scale)

Fatigue (FACIT Fatigue Scale v. 4)

Quality of Life (SF-36 Medical Outcomes Survey)

Secondary outcome measures

Acceptability (Acceptability of Intervention Measure)

Intervention Adherence

Usability (System Usability Scale)

Breathe Easier Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention GroupExperimental Treatment1 Intervention

Participants in this group will use the Breathe Easier progressive web application each day for a period of 8-weeks.

Group II: Non-intervention Group (Control Group)Active Control1 Intervention

Participants in this group will receive no intervention.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of South CarolinaLead Sponsor

211 Previous Clinical Trials

120,435 Total Patients Enrolled

Otis Owens, PhDPrincipal InvestigatorAssociate Professor

Karen McDonnell, PhDPrincipal InvestigatorAssociate Professor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are additional participants being solicited for this investigation?

"Evidently, clinicaltrials.gov does not indicate this research trial is actively recruiting any more participants; it was originally posted on October 2nd 2023 and last edited on September 22th 2023. Fortunately, there are numerous other trials that seeking enrolment right now with a total of 2086."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management

Otis (Shaun) Owens 2023. "Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06060964.